EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model

Aydar Uatay, Louis Gall, Linda Irons, Shivendra G Tewari, Xu Sue Zhu, Megan Gibbs, Holly Kimko

Journal of Pharmaceutical Sciences · 2024

DOI: 10.1016/j.xphs.2023.10.032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Sciences, 2024. Verfasst von Aydar Uatay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Cambridge, United Kingdom. Electronic address: Aydar.Uatay@astranzeneca.co…. Hauptthemen laut MEDLINE: Network Pharmacology, Pharmacology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past several decades, mathematical modeling has been applied to increasingly wider scopes of questions in drug development. Accordingly, the range of modeling tools has also been evolving, as showcased by contributions of Jusko and colleagues: from basic pharmacokinetics/pharmacodynamics (PK/PD) modeling to today's platform-based approach of quantitative systems pharmacology (QSP) modeling. Aimed at understanding the mechanism of action of investigational drugs, QSP models characterize systemic effects by incorporating information about cellular signaling networks, which is often represented by omics data. In this perspective, we share a few examples illustrating approaches for the integration of omics into mechanistic QSP modeling. We briefly overview how the evolution of PK/PD modeling into QSP has been accompanied by an increase in available data and the complexity of mathematical methods that integrate it. We discuss current gaps and challenges of integrating omics data into QSP models and propose several potential areas where integrated QSP and omics modeling may benefit drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Network PharmacologyPharmacologyModels, BiologicalModels, TheoreticalDrug DevelopmentDrugs, Investigational

Substanzen

Drugs, Investigational

Autor:innen und Institutionen

  • Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Cambridge, United Kingdom. Electronic address: Aydar.Uatay@astranzeneca.com.
  • Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Cambridge, United Kingdom.
  • Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Waltham, MA, United States.
  • Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Gaithersburg, MD, United States.
  • Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Gaithersburg, MD, United States. Electronic address: Holly.Kimko@astrazeneca.com.

Förderung

  • AstraZeneca

Zitieren

APA

Uatay, A., Gall, L., Irons, L., Tewari, S. G., Zhu, X. S., Gibbs, M., & Kimko, H. (2024). Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model. Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.xphs.2023.10.032

Vancouver

Uatay A, Gall L, Irons L, Tewari SG, Zhu XS, Gibbs M, et al. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model. Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.xphs.2023.10.032

BibTeX
@article{Uatay2024,
  author = {Uatay, Aydar and Gall, Louis and Irons, Linda and Tewari, Shivendra G and Zhu, Xu Sue and Gibbs, Megan and Kimko, Holly},
  title = {Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model},
  journal = {Journal of Pharmaceutical Sciences},
  year = {2024},
  doi = {10.1016/j.xphs.2023.10.032}
}
Kostenlos starten →